ストックスクリーナーアプリを入手
57.78
1.10%
0.63
前日終値:
$57.15
開ける：
$57.6
24時間の取引高:
11.69M
Relative Volume:
0.72
時価総額：
$85.88B
収益：
$20.62B
当期純損益:
$3.56B
株価収益率:
24.23
EPS:
2.3847
ネットキャッシュフロー:
$3.48B
1週間 パフォーマンス:
+9.68%
1か月 パフォーマンス:
-10.93%
6か月 パフォーマンス:
-40.36%
1年 パフォーマンス:
-44.71%
1日の値動き範囲:
$57.39
$58.51
1週間の範囲:
$53.45
$58.51
52週間の値動き範囲:
$52.52
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-30 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
| 2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-04-16 | アップグレード | Needham | Hold → Buy |
| 2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-10-18 | ダウングレード | Needham | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-12-22 | 開始されました | Mizuho | Neutral |
| 2022-12-20 | 再開されました | Citigroup | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-06 | 開始されました | Wolfe Research | Outperform |
| 2022-05-27 | アップグレード | Needham | Hold → Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-05-26 | ダウングレード | Needham | Buy → Hold |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Buy |
| 2019-12-30 | 繰り返されました | Cowen | Outperform |
| 2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-09-05 | 再開されました | JP Morgan | Overweight |
| 2019-09-03 | 再開されました | Barclays | Overweight |
| 2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
| 2018-09-07 | 繰り返されました | Needham | Strong Buy |
| 2018-09-04 | アップグレード | Jefferies | Hold → Buy |
| 2018-07-06 | 繰り返されました | Needham | Strong Buy |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific (BSX) Invests $1.5B in MiRus for Significant E - GuruFocus
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific’s SWOT analysis: stock navigates strategic expansion - Investing.com
Rx Rundown: Parabilis Medicines, Boston Scientific, Amgen and more - Medical Marketing and Media
Insider Buying: Cheryl Pegus Acquires Shares of Boston Scientifi - GuruFocus
Boston Scientific director Cheryl Pegus buys $99,987 in stock - Investing.com UK
Boston Scientific director Ludwig buys $202,914 in stock By Investing.com - Investing.com Australia
Boston Scientific director Ludwig buys $202,914 in stock - Investing.com
Director Cheryl Pegus buys Boston Scientific (BSX) shares in open-market trade - Stock Titan
Director Edward J. Ludwig buys 3,580 Boston Scientific (BSX) shares in open market - Stock Titan
Boston Scientific (NYSE: BSX) director adds 4,450 company shares - Stock Titan
Boston Scientific Corp (NYSE:BSX) GARP Growth at a Reasonable Price Meets Strong Fundamentals - ChartMill
BSX Stock Price, Quote & Chart | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Boston Scientific’s strategic investment in MiRus includes option to acquire TAVR system - Today's Medical Developments
Mengis Capital Management, Inc.'s Boston Scientific Corp(BSX) Holding History - GuruFocus
Subgroup analysis of the Champion-AF trial shows age not a factor - BioWorld News
Boston Scientific stock (US10117L1017): Q1 sales rise as Wall Street tracks procedure demand - AD HOC NEWS
Boston Scientific Corporation (BSX) Fell Due to Weak Results - Yahoo Finance
Baird Maintains Bullish View on Boston Scientific (BSX) Despite Lower Target - Insider Monkey
ODDO BHF ASSET MANAGEMENT SAS's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp. stock (US10117L1017): market eyes next catalysts after recent updates - AD HOC NEWS
OXFORD ASSET MANAGEMENT LLP's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX) Achieves Positive Results in CAD Treatme - GuruFocus
Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results - Benzinga
Boston Scientific reports Seismiq IVL data from Fracture study - BioWorld News
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial - Yahoo Finance
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Piper Sandler reiterates Boston Scientific stock rating on device outlook - Investing.com
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? - Yahoo Finance
Boston Scientific coronary device meets trial endpoints - Investing.com
Boston Scientific posts positive data for coronary IVL catheter - Yahoo Finance
Trial of new heart device leaves 93% free of major cardiac events - Stock Titan
Boston Scientific invests $1.5bn for equity stake in MiRus - Yahoo Finance
Boston Scientific Corp (BSX) Stock Up 6.2% and Still Undervalued -- GF Score: 83/100 - GuruFocus
Boston Scientific stock (US10117L1017): New catalyst watch after recent company developments - AD HOC NEWS
Boston Scientific Pairs US$2b Buyback With MiRus TAVR Growth Bet - Yahoo Finance
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Joel Greenblatt's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX) Announces $2 Billion Accelerated Share R - GuruFocus
Boston Scientific Corp Stock (BSX) Closed Up by 5.88% on May 18: Facts Behind the Movement - TradingKey
Boston Scientific invests $1.5B in MiRus heart valve startup - Yahoo Finance
Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal - Benzinga
BSX Reiterated by Needham -- Price Target Maintained at $77.00 - GuruFocus
Boston Scientific Bets on Growth Through Strategic M&A Deals - Yahoo Finance
Boston Scientific (BSX) Invests $1.5B in MiRus for 34% Equity St - GuruFocus
Boston Scientific returns to heart-valve market with $1.5B investment in startup - The Business Journals
Boston Scientific Invests $1.5 Billion in MiRus for Exclusive Option on Innovative Nickel-Free Balloon Expandable TAVR Valve - Minichart
Boston Scientific Announces $2 Billion Accelerated Share Repurchase Agreement to Boost Shareholder Value - Minichart
Truist reiterates Boston Scientific stock rating on MiRus deal - Investing.com
Boston Scientific (BSX) Invests $1.5B in MiRus for Cardiovascula - GuruFocus
Why is Boston Scientific stock rallying today? - Investing.com
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
0.58%
0.16%
大文字化:
|
ボリューム (24 時間):